United Therapeutics (UTHR) Prepaid Assets (2009 - 2026)
United Therapeutics (UTHR) reported Prepaid Assets of $228.0 million for Q1 2026, up 73.91% on a YoY basis from $131.1 million in Q1 2025, and down 8.4% sequentially from $248.9 million in Q4 2025.
United Therapeutics (UTHR) Prepaid Assets (2009 - 2026) Analysis & Trends
United Therapeutics (UTHR) has 18 years of Prepaid Assets data on file, last reported at $228.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 73.91% year-over-year to $228.0 million; the trailing twelve-month figure through Mar 2026 stood at $228.0 million (up 73.91% YoY), and the FY2025 full-year result was $248.9 million, up 46.67% from the prior year.
- Prepaid Assets fell to $228.0 million in Q1 2026, from $248.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $252.2 million in Q3 2025 to a low of $60.2 million in Q1 2022.
- A 5-year average of $175.3 million and a median of $169.7 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets jumped 118.33% in 2022 and declined 24.18% in 2023, its largest moves.
- Tracing UTHR's Prepaid Assets over 5 years: stood at $219.2 million in 2022, then fell by 24.18% to $166.2 million in 2023, then grew by 2.11% to $169.7 million in 2024, then jumped by 46.67% to $248.9 million in 2025, then decreased by 8.4% to $228.0 million in 2026.
- Business Quant data shows UTHR's Prepaid Assets at $228.0 million in Q1 2026, $248.9 million in Q4 2025, and $252.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228.00 Mn |
| Dec 31, 2025 | 248.90 Mn |
| Sep 30, 2025 | 252.20 Mn |
| Jun 30, 2025 | 229.70 Mn |
| Mar 31, 2025 | 131.10 Mn |
| Dec 31, 2024 | 169.70 Mn |
| Sep 30, 2024 | 185.40 Mn |
| Jun 30, 2024 | 220.80 Mn |
| Mar 31, 2024 | 113.40 Mn |
| Dec 31, 2023 | 166.20 Mn |
| Sep 30, 2023 | 220.50 Mn |
| Jun 30, 2023 | 158.40 Mn |
| Mar 31, 2023 | 92.60 Mn |
| Dec 31, 2022 | 219.20 Mn |
| Sep 30, 2022 | 118.10 Mn |
| Jun 30, 2022 | 165.80 Mn |
| Mar 31, 2022 | 60.20 Mn |
| Dec 31, 2021 | 100.40 Mn |
| Sep 30, 2021 | 76.00 Mn |
| Jun 30, 2021 | 87.10 Mn |